Claudio D'amore
Via U. Bassi 58/B
Padova, 35131, Italy
Padova, 35131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Regulation of the cell secretome by protein kinase CK2 modulates cell migration and extracellular matrix composition.
Journal: International journal of biological macromolecules
Published: May 20, 2025
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant.
Journal: International journal of molecular sciences
Published: December 13, 2023
Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells.
Journal: Open biology
Published: February 22, 2023
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR.
Journal: International journal of molecular sciences
Published: July 28, 2022
Development of small cyclic peptides targeting the CK2α/β interface.
Journal: Chemical communications (Cambridge, England)
Published: March 28, 2022
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants.
Journal: Cellular and molecular life sciences : CMLS
Published: January 26, 2022
Nitrobenzoxadiazole derivatives of the rat selective toxicant norbormide as fluorescent probes for live cell imaging.
Journal: Bioorganic & medicinal chemistry
Published: December 14, 2021
How can a traffic light properly work if it is always green? The paradox of CK2 signaling.
Journal: Critical reviews in biochemistry and molecular biology
Published: April 12, 2021
Editorial of Special Issue "Protein Post-Translational Modifications in Signal Transduction and Diseases".
Journal: International journal of molecular sciences
Published: February 20, 2021
A mutational approach to dissect the functional role of the putative CFTR "PTM-CODE".
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: December 23, 2020
Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
Journal: European journal of medicinal chemistry
Published: December 09, 2020
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 28, 2020
Last Updated: 09/26/2026